Concurrent sunitinib and stereotactic body radiotherapy for patients with oligometastases
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Concurrent sunitinib and stereotactic body radiotherapy for patients with oligometastases
Authors
Keywords
Sunitinib, Stereotactic body radiation therapy (SBRT), Oligometastases, Image-guided radiation therapy, Metastases
Journal
Targeted Oncology
Volume 9, Issue 2, Pages 145-153
Publisher
Springer Nature
Online
2013-05-09
DOI
10.1007/s11523-013-0280-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
- (2012) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase II Trial of Concurrent Sunitinib and Image-Guided Radiotherapy for Oligometastases
- (2012) Charles C. L. Tong et al. PLoS One
- Stereotactic body radiotherapy for multisite extracranial oligometastases
- (2011) Joseph K. Salama et al. CANCER
- Oligometastases Treated With Stereotactic Body Radiotherapy: Long-Term Follow-Up of Prospective Study
- (2011) Michael T. Milano et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Treatment-Related Mortality With Bevacizumab in Cancer Patients
- (2011) Vishal Ranpura et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Targeting immune suppressing myeloid-derived suppressor cells in oncology
- (2010) Johnny Kao et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis
- (2009) Kyle E. Rusthoven et al. ACTA ONCOLOGICA
- Local Surgical, Ablative, and Radiation Treatment of Metastases
- (2009) R. D. Timmerman et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases
- (2009) Johnny Kao et al. CANCER
- The Novel Role of Tyrosine Kinase Inhibitor in the Reversal of Immune Suppression and Modulation of Tumor Microenvironment for Immune-Based Cancer Therapies
- (2009) J. Ozao-Choy et al. CANCER RESEARCH
- Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients
- (2009) J. S. Ko et al. CLINICAL CANCER RESEARCH
- Phase I Study of Individualized Stereotactic Body Radiotherapy of Liver Metastases
- (2009) Mark T. Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases
- (2009) Kyle E. Rusthoven et al. JOURNAL OF CLINICAL ONCOLOGY
- Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver Metastases
- (2009) Kyle E. Rusthoven et al. JOURNAL OF CLINICAL ONCOLOGY
- From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
- (2009) R. L. Wahl et al. JOURNAL OF NUCLEAR MEDICINE
- An Initial Report of a Radiation Dose-Escalation Trial in Patients with One to Five Sites of Metastatic Disease
- (2008) J. K. Salama et al. CLINICAL CANCER RESEARCH
- A quantitative analysis of kinase inhibitor selectivity
- (2008) Mazen W Karaman et al. NATURE BIOTECHNOLOGY
- Normal tissue toxicity after small field hypofractionated stereotactic body radiation
- (2008) Michael T Milano et al. Radiation Oncology
- A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions
- (2007) Michael T. Milano et al. CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started